CytomX Therapeutics, Inc. Named a 2013 Red Herring Top 100 North America Tech Startup
6/3/2013 11:00:52 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAN FRANCISCO--(BUSINESS WIRE)--CytomX Therapeutics, Inc., a biotechnology company developing a new generation of targeted antibody therapeutics, today announced that it has been selected as a 2013 Red Herring Top 100 North America Tech Startup. Red Herring Top 100 awards recognize the leading private companies from the Americas, celebrating these startups’ innovations and technologies across their respective industries. CytomX was selected after presenting along with hundreds of finalists at the Red Herring Top 100 North America event in Monterey, Calif.
Help employers find you! Check out all the jobs and post your resume.
comments powered by